Your browser doesn't support javascript.
loading
The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms.
Bertinetto, Francesca Eleonora; Magistroni, Paola; Mazzola, Gina Adriana; Costa, Cristina; Elena, Garino; Alizzi, Silvia; Scozzari, Gitana; Migliore, Enrica; Galassi, Claudia; Ciccone, Giovannino; Ricciardelli, Guido; Scarmozzino, Antonio; Angelone, Lorenzo; Cassoni, Paola; Cavallo, Rossana; Vaisitti, Tiziana; Deaglio, Silvia; Amoroso, Antonio.
Affiliation
  • Bertinetto FE; Immunogenetics and Transplant Biology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Magistroni P; Immunogenetics and Transplant Biology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Mazzola GA; Immunogenetics and Transplant Biology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Costa C; Microbiology and Virology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Elena G; Department of Public Health and Pediatric Sciences, University of Turin, 10126, Turin, Italy.
  • Alizzi S; Immunogenetics and Transplant Biology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Scozzari G; Microbiology and Virology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Migliore E; Department of Medical Sciences, University of Turin, 10126, Turin, Italy.
  • Galassi C; Molinette Hospital Medical Direction, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Ciccone G; Clinical Epidemiology Unit, Città Della Salute e Della Scienza di Torino and CPO Piemonte, University Hospital, 10126, Turin, Italy.
  • Ricciardelli G; Clinical Epidemiology Unit, Città Della Salute e Della Scienza di Torino and CPO Piemonte, University Hospital, 10126, Turin, Italy.
  • Scarmozzino A; Clinical Epidemiology Unit, Città Della Salute e Della Scienza di Torino and CPO Piemonte, University Hospital, 10126, Turin, Italy.
  • Angelone L; Microbiology and Virology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Cassoni P; Department of Public Health and Pediatric Sciences, University of Turin, 10126, Turin, Italy.
  • Cavallo R; Molinette Hospital Medical Direction, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Vaisitti T; Molinette Hospital Medical Direction, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
  • Deaglio S; Pathology Unit, Department of Medical Sciences, University of Turin, 10126, Turin, Italy.
  • Amoroso A; Microbiology and Virology Unit, Città Della Salute e Della Scienza di Torino, University Hospital, 10126, Turin, Italy.
HLA ; 102(3): 301-315, 2023 09.
Article in En | MEDLINE | ID: mdl-37010080
ABSTRACT
Host genetic variability contributes to susceptibility to SARS-CoV-2 infection and COVID-19 evolution and the role of HLA system has not clearly emerged, suggesting the involvement of other factors. Studying response to vaccination with Spyke protein mRNA represents an ideal model to highlight whether the humoral or cellular responses are influenced by HLA. Four hundred and sixteen workers, vaccinated with Comirnaty beginning 2021, were selected within the Azienda Ospedaliera Universitaria "Città della Salute e della Scienza di Torino." The humoral response was determined with the LIAISON® kit, while the analysis of the cellular response was performed with the Quantiferon SARS-CoV-2 assay, for the S1 (receptor-binding domain; Ag1) and S1 and S2 (Ag2) subunits of the Spyke protein. Six HLA loci were typed by next-generation sequencing. Associations between HLA and vaccine response were performed with univariate and multivariate analyses. An association was found between A*0301, B*4002 and DPB1*0601 and high antibody concentration and between A*2402, B*0801 and C*0701 and low humoral responses. The haplotype HLA-A*0101 ~ B1*0801 ~ C*0701 ~ DRB1*0301 ~ DQB1*0201 conferred an increased risk of low humoral response. Considering cellular responses, 50% of the vaccinated subjects responded against Ag1 and 59% against Ag2. Carriers of DRB1*1501 displayed a higher cellular response both to Ag1 and Ag2 compared to the rest of the cohort. Similarly, DRB1*1302 predisposed to a robust cellular response to Ag1 and Ag2, while DRB1*1104 showed an opposite trend. Cellular and humoral responses to Comirnaty are influenced by HLA. Humoral response is mainly associated to class I alleles, with A*0301, previously associated to protection against severe COVID-19, and response to vaccination, standing out. Cellular response predominantly involves class II alleles, with DRB1*1501 and DPB1*1301 prevailing. Affinity analysis for Spyke peptides is generally in line with the association results.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: HLA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: HLA Year: 2023 Document type: Article Affiliation country:
...